Delivery Order SPE2DE24D0018-SPE2D626F4787
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $103.2K delivery order to Meso Scale Diagnostics LLC (doing business as Meso Scale Discovery) on August 28, 2025, for a multiplex serology assay for IgG antibodies. This delivery order, issued under a fixed-price contract with economic price adjustment provisions, is part of a larger $25 million indefinite delivery contract vehicle between the agency and the Native American-owned small business. The work will be performed in...
- The U.S. Department of Defense awarded a $65,526 delivery order to Meso Scale Diagnostics LLC (doing business as Meso Scale Discovery) on August 8, 2025, for the manufacture of biodefense assay kits and performance qualification kits in support of joint military services and the Department of the Army. The contract is a firm fixed-price delivery order with completion scheduled for October 10, 2025, and performance will occur in Potomac, Maryland. This award was made without a small business...
- This is a definitive contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Meso Scale Diagnostics LLC, a for-profit, limited liability company that is Native American-owned. The $1,609,769.00 firm-fixed-price contract is for the provision of meso scale defense biological agent test kits. The contract has a completion date of September 30, 2018. Meso Scale Diagnostics is a provider of assay development services, laboratory testing...
- This is a federal contract award to Meso Scale Diagnostics LLC, a for-profit limited liability company and Native American-owned small business, to manufacture biodefense assay kits and performance qualification kits in support of the U.S. Joint Military Service, Department of Defense, and Department of Homeland Security. The contract, awarded by the Joint PEO Chemical and Biological Defense, is a firm-fixed price delivery order with a ceiling value of $350,966.87 and a period of performance...
- The U.S. government awarded a purchase order valued at $12,927.50 to Meso Scale Diagnostics LLC (doing business as Meso Scale Discovery), a Native American-owned small business based in Rockville, Maryland. The contract, issued under references K15173-5 and K151RPD-5 by the Pacific West Area civilian agency, was awarded on April 3, 2020, with a completion date of April 30, 2020. This firm fixed-price purchase order was awarded without a set-aside designation and will be performed in Potomac,...
- Meso Scale Diagnostics LLC, a Native American-owned small business based in Rockville, Maryland and operating as Meso Scale Discovery, was awarded a $4,534.25 firm fixed price purchase order on July 26, 2016, for V-PLEX custom human cytokine assay products. The contract, which was not set aside for any small business category, is scheduled for completion by September 30, 2016, with performance taking place in Davis, California. The funding agency is a civilian component of the Pacific West...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,162.10 fixed-price delivery order to Meso Scale Diagnostics LLC (doing business as Meso Scale Discovery) on October 14, 2025, for measuring IgG antibodies to influenza A/Hong Kong. The work will be performed in Potomac, Maryland, with an ultimate completion date of November 3, 2025. This delivery order is issued under a larger Indefinite Delivery Contract vehicle with the Defense Logistics Agency's Medical Supply Chain, which...
- The U.S. Defense Department, through the Washington Headquarters Service, awarded a $34.5K firm fixed-price purchase order to Meso Scale Diagnostics LLC (doing business as Meso Scale Discovery) on May 1, 2025, for the MSD QuickPlex PM product line. The contract will be performed in Dahlgren, Virginia, with completion targeted for April 30, 2026. This award does not utilize a small business set-aside, despite the vendor being a Native American-owned small business based in Rockville, Maryland....
- The U.S. civilian government agency Pacific West Area awarded a $15,606.80 purchase order to Meso Scale Diagnostics LLC (doing business as Meso Scale Discovery) on January 28, 2016, with a completion date of February 19, 2016. The contract, issued under firm fixed pricing with no small business set-aside, procures a Meso Scale Discovery N45CA-1 Multi-Spot 96 4-Spot Custom Human B2M assay platform for delivery to Potomac, Maryland. Meso Scale Diagnostics is a Native American-owned small...
- The U.S. Department of Commerce's Pacific West Area office awarded a $16,246.40 firm fixed-price purchase order to Meso Scale Diagnostics LLC (doing business as Meso Scale Discovery) on June 16, 2021, with an ultimate completion date of July 16, 2021. This contract, classified as an MSD Assay procurement, was issued without a small business set-aside. Meso Scale Diagnostics, a Native American-owned small business headquartered in Rockville, Maryland, will perform the work at its Davis,...
- SPE2DE24D0018Indefinite Delivery Contract
- SPE2DE24D0018-SPE2D626F4787Delivery Order
Meso Scale Diagnostics LLC, a Native American-owned small business specializing in advanced biomedical research technologies, was awarded a delivery order valued at $5,625.75 for a multiplex serology assay for IgG antibodies. The award was issued on October 24, 2025, with an ultimate completion date of November 12, 2025, under a fixed-price contract with economic price adjustment terms. The work will be performed in Potomac, Maryland. This delivery order is issued under a broader Indefinite Delivery Contract with the Defense Logistics Agency's Medical Supply Chain, a $25 million single-award vehicle that enables flexible procurement of specialized scientific research products and reagents to support biomedical research and diagnostic efforts across the Department of Defense and affiliated health system missions. The contract represents a continuation of Meso Scale Diagnostics' ongoing support to federal agencies in developing and delivering immunoassay technologies. The company's electrochemiluminescence-based detection platforms have been leveraged across multiple federal agencies, including the National Institutes of Health, Centers for Disease Control and Prevention, and Defense Health Agency, supporting critical research initiatives ranging from infectious disease detection to biodefense applications. No small business set-aside was used for this award, allowing the contract to proceed on an unrestricted, full and open competition basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 10/24/25 |